- Home
- GHI vs MXCT Comparison
GHI vs MXCT Comparison
Compare GHI & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GHI
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Current Price
Company Overview
Basic Information| Metric | GHI | MXCT |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 160.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GHI | MXCT |
|---|---|---|
| Price | $8.11 | $1.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $13.00 | $7.50 |
| AVG Volume (30 Days) | 168.8K | ★ 558.1K |
| Earning Date | 02-19-2026 | 03-10-2026 |
| Dividend Yield | ★ 19.27% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $26,247,399.00 | ★ $34,419,000.00 |
| Revenue This Year | $201.02 | N/A |
| Revenue Next Year | $2.87 | $11.16 |
| P/E Ratio | $45.52 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.01 | $1.19 |
| 52 Week High | $13.29 | $5.20 |
Technical Indicators
Market Signals| Indicator | GHI | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 62.47 | 31.62 |
| Support Level | $7.63 | $1.19 |
| Resistance Level | $8.06 | $1.37 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 97.25 | 15.00 |
Price Performance
Historical ComparisonAbout GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.